Clinical Trials Browser

INDUSTRY × Mesothelioma, Malignant × 30 days × Clear all

Diabetes Mellitus, Insulin-Dependent, 12, Mesothelioma, Malignant

NCT06097728 2026-03-04

eVOLVE-Meso

Phase 3 Recruiting

825 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT06051695 2026-02-20

EVEREST-2

Phase 1/2 Recruiting

474 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Colorectal Neoplasms

Clinical Trials

Tremelimumab

eVOLVE-Meso

EVEREST-2